What is TTRX's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.32B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for TTRX?

P/E (TTM) is n/a and 52-week range is $2.57 to $16.45 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s TTRX figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for TTRX?

The company profile lists net income (TTM) near -$9M, EPS (TTM) near -$0.29 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Turn Therapeutics Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Westlake Village, California, US, 30.5M shares outstanding, ISIN US90021W1053 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Turn Therapeutics Inc

$TTRX

Health Care · Pharmaceuticals

Run Scenarios

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. The company is headquartered in Westlake Village, California. The company went IPO on 2025-10-08. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.

Website

turntherapeutics.com

IPO

2025-10-08

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)